Integral Derivatives’s Bunge Global BG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-10,321
Closed -$702K 1130
2017
Q3
$717K Buy
+10,321
New +$781K 0.01% 615
2016
Q2
Sell
-71,523
Closed -$4.05M 951
2016
Q1
$4.05M Buy
+71,523
New +$4.08M 0.13% 117
2015
Q4
Sell
-33,939
Closed -$2.39M 1067
2015
Q3
$2.49M Buy
+33,939
New +$2.63M 0.07% 249
2015
Q2
Sell
-11,467
Closed -$1.02M 1103
2015
Q1
$944K Sell
11,467
-10,877
-49% -$929K 0.02% 525
2014
Q4
$2.03M Sell
22,344
-9,508
-30% -$837K 0.04% 435
2014
Q3
$2.68M Buy
+31,852
New +$2.57M 0.05% 364
2014
Q2
Sell
-13,772
Closed -$1.07M 1350
2014
Q1
$1.09M Buy
13,772
+3,400
+33% +$268K 0.02% 623
2013
Q4
$852K Buy
+10,372
New +$837K 0.01% 845

Other funds holding BG

Integral Derivatives's BG Position: Q4 2017 in Review

Integral Derivatives sold out of Bunge Global (BG) in Q4 2017, closing a stake of 10,321 shares — an estimated $702K sold.

Integral Derivatives first reported a position in BG in Q4 2013 and held it in 8 quarters. The position peaked at $4.05M in Q1 2016. 387 funds tracked by Wall St. Rank hold BG as of Q4 2017.

  • Integral Derivatives reported no remaining Bunge Global position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 10,321 Bunge Global shares in Q4 2017, an estimated $702K.
  • Integral Derivatives first reported a position in Bunge Global in Q4 2013 and held it in 8 quarters.
  • Integral Derivatives's Bunge Global position peaked at $4.05M in Q1 2016.
  • 387 funds tracked by Wall St. Rank held Bunge Global as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.